Wednesday, February 10, 2010, 3:06pm SGT - The Singapore stock market closes in 1 hour and 54 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Abiomed Inc. (ABMD)

At 5:00AM SGT: 9.34 USD  Up 0.48 (5.42%)  
 MORE ON ABMD 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ABIOMED, Inc. (NGM:ABMD) Delayed quote dataEdit
After Hours: 9.34 0.00 (0.00%) as of 5:34am SGT on 02/10/10
Last Trade:9.34 USD
Trade Time:5:00AM SGT
Change:Up 0.48 (5.42%)
Prev Close:8.86
Open:8.97
Bid:8.94 x 200
Ask:9.74 x 200
1y Target Est:10.83
Day's Range:8.91 - 9.35
52wk Range:4.67 - 11.25
Volume:508,749
Avg Vol (3m):247,686
Market Cap:350.11M
P/E (ttm):N/A
EPS (ttm):-0.86
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ABMD to Portfolio   Download Data

 HEADLINES 
•Abiomed Beats Zacks Estimate
Zacks.com (Mon, Feb 8)
•New Star Analyst Rankings for ABIOMED, Inc.
StarMine (Sun, Feb 7)
•ABIOMED INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Feb 6)
•Abiomed fiscal 3Q loss narrows on Impella sales
AP (Fri, Feb 5)
•UPDATE - Abiomed posts narrower loss, trims FY revenue view
at Reuters (Thu, Feb 4)
•ABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
•Q3 2010 Abiomed, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Feb 4)
•Abiomed Reports Third Quarter Fiscal 2010 Financial Results
Business Wire (Thu, Feb 4)
•Abiomed Third Fiscal Quarter 2010 Earnings and Conference Call Notification
Business Wire (Thu, Jan 28)
•Abiomed Announces Partnership with Opsens to Utilize Sensor Technology for Impella
Business Wire (Wed, Jan 27)
•Impella 2.5 Patient Procedure at Mount Sinai Medical Center Featuring New Product Enhancements: Webcast Available
Business Wire (Mon, Jan 25)
More Headlines for ABMD...
 ANALYST 
EPS Est (next year) (Mar-10) :-0.75
EPS Est (in 2 years) (Mar-11) :-0.53
Avg Rec (current)*:2.9
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Abiomed, Inc. and its subsidiaries manufacture and sell medical devices in circulatory support that offer a continuum of care in heart recovery to acute heart failure patients.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices